The role of RHIM in necroptosis.


Journal

Biochemical Society transactions
ISSN: 1470-8752
Titre abrégé: Biochem Soc Trans
Pays: England
ID NLM: 7506897

Informations de publication

Date de publication:
31 08 2022
Historique:
received: 22 06 2022
revised: 05 08 2022
accepted: 09 08 2022
entrez: 30 8 2022
pubmed: 31 8 2022
medline: 3 9 2022
Statut: ppublish

Résumé

The RIP homotypic interaction motif (RHIM) is a conserved protein domain that is approximately 18-22 amino acids in length. In humans, four proteins carrying RHIM domains have been identified: receptor-interacting serine/threonine protein kinase (RIPK) 1, RIPK3, Z-DNA-binding protein 1 (ZBP1), and TIR domain-containing adapter-inducing IFN-β (TRIF), which are all major players in necroptosis, a distinct form of regulated cell death. Necroptosis is mostly presumed to be a fail-safe form of cell death, occurring in cells in which apoptosis is compromised. Upon activation, RIPK1, ZBP1, and TRIF each hetero-oligomerize with RIPK3 and induce the assembly of an amyloid-like structure of RIPK3 homo-oligomers. These act as docking stations for the recruitment of the pseudokinase mixed-lineage kinase domain like (MLKL), the pore-forming executioner of necroptosis. As RHIM domain interactions are a vital component of the signaling cascade and can also be involved in apoptosis and pyroptosis activation, it is unsurprising that viral and bacterial pathogens have developed means of disrupting RHIM-mediated signaling to ensure survival. Moreover, as these mechanisms play an essential part of regulated cell death signaling, they have received much attention in recent years. Herein, we present the latest insights into the supramolecular structure of interacting RHIM proteins and their distinct signaling cascades in inflammation and infection. Their uncovering will ultimately contribute to the development of new therapeutic strategies in the regulation of lytic cell death.

Identifiants

pubmed: 36040212
pii: 231698
doi: 10.1042/BST20220535
pmc: PMC9444067
doi:

Substances chimiques

Adaptor Proteins, Vesicular Transport 0
Carrier Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1197-1205

Informations de copyright

© 2022 The Author(s).

Références

Cell Microbiol. 2015 Mar;17(3):318-32
pubmed: 25588886
Nat Commun. 2021 Jan 4;12(1):86
pubmed: 33397971
EMBO J. 2020 Dec 1;39(23):e105753
pubmed: 33124082
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3094-9
pubmed: 18287053
Clin Pharmacol Ther. 2020 Oct;108(4):808-816
pubmed: 32301501
EMBO Rep. 2019 Feb;20(2):
pubmed: 30498077
Cell Rep. 2020 May 19;31(7):107650
pubmed: 32433959
J Mol Biol. 2020 Nov 20;432(23):6005-6027
pubmed: 33058872
Physiol Rev. 2022 Jan 1;102(1):411-454
pubmed: 34898294
Nat Cell Biol. 2022 Apr;24(4):471-482
pubmed: 35256774
Science. 2022 May 6;376(6593):609-615
pubmed: 35511979
Cell Death Differ. 2019 Sep;26(9):1631-1645
pubmed: 30442947
Nature. 2022 Jul;607(7920):784-789
pubmed: 35859175
Cell Host Microbe. 2010 Apr 22;7(4):302-313
pubmed: 20413098
Sci Signal. 2021 Feb 02;14(668):
pubmed: 33531383
J Virol. 2018 Mar 14;92(7):
pubmed: 29321311
Cell Host Microbe. 2015 Feb 11;17(2):243-51
pubmed: 25674983
Nat Immunol. 2004 May;5(5):503-7
pubmed: 15064760
Curr Opin Microbiol. 2021 Feb;59:58-64
pubmed: 32862049
EMBO Rep. 2019 Feb;20(2):
pubmed: 30665943
Cell Mol Life Sci. 2016 Jun;73(11-12):2137-52
pubmed: 27052312
J Biol Chem. 2013 Oct 25;288(43):31268-79
pubmed: 24019532
Cell Mol Immunol. 2020 Apr;17(4):356-368
pubmed: 31076724
Cell Res. 2011 Oct;21(10):1410-23
pubmed: 21931360
J Immunol. 2008 Nov 1;181(9):6427-34
pubmed: 18941233
Am J Transplant. 2013 Feb;13 Suppl 3:1-8; quiz 8
pubmed: 23347210
J Biol Chem. 2002 Mar 15;277(11):9505-11
pubmed: 11734559
J Biol Chem. 2008 Jun 20;283(25):16966-70
pubmed: 18442983
Cell Death Differ. 2021 Jan;28(1):251-266
pubmed: 32737444
Semin Cell Dev Biol. 2020 Mar;99:86-95
pubmed: 29738881
Nat Immunol. 2018 Sep;19(9):912-922
pubmed: 30131615
mBio. 2022 Jun 28;13(3):e0040122
pubmed: 35587190
J Immunol. 2005 Apr 15;174(8):4942-52
pubmed: 15814722
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32797196
Elife. 2019 Jul 09;8:
pubmed: 31287416
Nature. 2022 Jul;607(7920):769-775
pubmed: 35859177
Nat Commun. 2021 Mar 12;12(1):1627
pubmed: 33712586
Sci Signal. 2022 May 17;15(734):eabn5881
pubmed: 35580168
J Clin Invest. 2018 May 1;128(5):2064-2075
pubmed: 29664014
Biochem J. 2022 Feb 11;479(3):259-272
pubmed: 35015082
Nat Rev Dis Primers. 2015 Jul 02;1:15016
pubmed: 27188665
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9714-9722
pubmed: 31048504
J Infect Dis. 2016 Oct 1;214 Suppl 2:S67-74
pubmed: 27625433
Viruses. 2021 Aug 27;13(9):
pubmed: 34578288
EMBO J. 2020 Sep 1;39(17):e104469
pubmed: 32657447
Proc Natl Acad Sci U S A. 2021 Apr 6;118(14):
pubmed: 33790016
Trends Immunol. 2019 May;40(5):387-402
pubmed: 31003931
Front Cell Dev Biol. 2020 Aug 21;8:817
pubmed: 32974349
EMBO Rep. 2009 Aug;10(8):916-22
pubmed: 19590578
Nat Microbiol. 2017 Jan 13;2:16258
pubmed: 28085133
Nat Commun. 2020 Jun 19;11(1):3151
pubmed: 32561730
J Biol Chem. 2019 Jan 18;294(3):991-1004
pubmed: 30504227
J Immunol. 2018 Jun 15;200(12):3881-3889
pubmed: 29866770
Cell Host Microbe. 2016 Jul 13;20(1):13-24
pubmed: 27321907
Cell Death Differ. 2022 Sep;29(9):1804-1815
pubmed: 35264780
Cell. 2020 Apr 30;181(3):674-687.e13
pubmed: 32298652
Cell Rep. 2021 May 11;35(6):109112
pubmed: 33979622
Cell Death Differ. 2019 Jan;26(1):4-13
pubmed: 30050058
Nat Rev Neurosci. 2019 Jan;20(1):19-33
pubmed: 30467385
Cell. 2012 Jul 20;150(2):339-50
pubmed: 22817896
Nature. 2020 Apr;580(7803):391-395
pubmed: 32296175
Cell Host Microbe. 2012 Mar 15;11(3):290-7
pubmed: 22423968
PLoS Pathog. 2020 Jul 10;16(7):e1008473
pubmed: 32649716
Cell Death Dis. 2018 Jul 26;9(8):816
pubmed: 30050136
Cell Rep. 2017 Apr 4;19(1):175-187
pubmed: 28380356
Immunity. 2021 Feb 9;54(2):247-258.e7
pubmed: 33444549
Cell. 2018 May 17;173(5):1244-1253.e10
pubmed: 29681455
J Leukoc Biol. 2019 Feb;105(2):363-375
pubmed: 30517972
Immunol Rev. 2020 Sep;297(1):26-38
pubmed: 32729116
Cell. 2012 Jan 20;148(1-2):213-27
pubmed: 22265413
Cell. 2009 Jun 12;137(6):1112-23
pubmed: 19524513
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20054-9
pubmed: 22123964
Molecules. 2022 May 24;27(11):
pubmed: 35684320
Cold Spring Harb Perspect Biol. 2019 Dec 2;11(12):
pubmed: 31088827
Cell Host Microbe. 2015 Feb 11;17(2):229-42
pubmed: 25674982
Cell. 2020 Mar 19;180(6):1115-1129.e13
pubmed: 32200799
Am J Transplant. 2013 Nov;13(11):2797-804
pubmed: 24103029
Cell Death Differ. 2021 May;28(5):1610-1626
pubmed: 33273695
Nature. 2020 Jan;577(7788):103-108
pubmed: 31827281
Mol Biol Evol. 2021 Dec 9;38(12):5405-5422
pubmed: 34436583
Nature. 2022 Jun;606(7914):594-602
pubmed: 35614224
Nat Rev Microbiol. 2021 Jul;19(7):425-441
pubmed: 33824495
Nature. 2022 Jul;607(7920):776-783
pubmed: 35859176
Sci Rep. 2014 Dec 11;4:7436
pubmed: 25500536
Biophys Chem. 2021 Feb;269:106524
pubmed: 33348174
J Neuroinflammation. 2022 May 13;19(1):109
pubmed: 35549723
Curr Top Microbiol Immunol. 2020 Feb 15;:
pubmed: 32060646
J Exp Med. 2017 Aug 7;214(8):2217-2229
pubmed: 28634194

Auteurs

Theresa Riebeling (T)

Department of Nephrology and Hypertension, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.

Ulrich Kunzendorf (U)

Department of Nephrology and Hypertension, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.

Stefan Krautwald (S)

Department of Nephrology and Hypertension, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH